tirzepatide parkinson's A Big Week for GLP-1 Drugs - by Eric Topol Tirzepatide: a novel therapeutic approach

A: Current research suggests risks like pancreatitis, kidney problems, and muscle loss may increase with prolonged use

Huile dOnagre Nat&Form: tp trung vo cn bng ni tit giu GLA, chuyn ha thnh PGE1 gip n nh estrogen/progesterone, gim PMS, ci thin kh hn v cc ri lon tin mn kinh

Efficacy and safety of tirzepatide, a dual GIP and GLP1 receptor agonist, in patients with type 2 diabetes: A phase 2 trial

We employed a new-user, active-comparator design guided by target trial emulation principles, which is recommended to minimize immortal time bias and confounding by indication in observational drug safety research

This makes the plasma half-life about 165 hours longer

Therefore, it is crucial to investigate the mechanisms of MOTS-c in osteogenesis, osteolysis, and bone remodeling to reveal the role of MOTS-c in bone metabolism